RE: Who bought the shares?18 Sep 2025 12:06
Forget about the intraday dealings here and if MM's are playing games. Just check out Tempus NGS test and who we are collaborating with offering our tests.
"The unique Tempus platform, with its broad clinical reach, will allow us to significantly expand patient and clinician access to advanced kidneyintelX.dkd precision medicine testing in one of the largest and costliest chronic disease conditions today. Further, we expect our partnership to be instrumental in driving therapeutic and diagnostic innovation through multi-modal data accumulation and analysis in patients in the cardiovascular, renal and metabolic space"